JOURNAVX

Clinical trials for JOURNAVX explained in plain language.

Never miss a new study

Get alerted when new JOURNAVX trials appear

Sign up with your email to follow new studies for JOURNAVX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pain drug could cut opioid use after hip surgery

Symptom relief Recruiting now

This study tests suzetrigine, a new FDA-approved non-opioid pain medication, in 210 adults undergoing total hip replacement. Participants receive either suzetrigine or a placebo for seven days, starting before surgery. The goal is to see if suzetrigine reduces the amount of opioi…

Matched conditions: JOURNAVX

Phase: PHASE3 • Sponsor: Hospital for Special Surgery, New York • Aim: Symptom relief

Last updated Jun 27, 2026 13:01 UTC

JOURNAVX

Get alerted when new JOURNAVX trials appear

New pain drug could cut opioid use after hip surgery